Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DISCK
1126
CALL
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $24.3M | 0.01% |
1,000,000
+397,500
| +66% | +$10.6M |
|
1127
First American
FAF
$7.36B
| $24.2M | 0.01% |
361,644
+4,771
| +1% | +$319K |
|
1128
Southern Copper
SCCO
$182B
| $24.2M | 0.01% |
470,036
-76,600
| -14% | -$4.38M |
|
1129
Royal Bank of Canada
RY
$286B
| $24.2M | 0.01% |
242,769
+15,237
| +7% | +$1.55M |
|
1130
Nutanix
NTNX
$17.9B
| $24.1M | 0.01% |
639,948
+214,699
| +50% | +$8.12M |
|
1131
Option Care Health
OPCH
$3.54B
| $24.1M | 0.01% |
993,737
+645,522
| +185% | +$15M |
|
1132
Bruker
BRKR
$8.81B
| $24.1M | 0.01% |
308,671
-614,422
| -67% | -$51.1M |
|
1133
Sonos
SONO
$1.82B
| $24.1M | 0.01% |
744,469
-138,486
| -16% | -$4.99M |
|
1134
Medtronic
MDT
$117B
| $24.1M | 0.01% |
192,134
-1,384,839
| -88% | -$179M |
|
1135
PUT
iShares US Real Estate ETF
IYR
$4.66B
| $24.1M | 0.01% |
235,000
+167,500
| +248% | +$17.8M |
|
1136
Cohen & Steers
CNS
$4.24B
| $24.1M | 0.01% |
287,189
+105,537
| +58% | +$8.94M |
|
|
BLU
1137
DELISTED
BELLUS Health Inc.
BLU
| $24M | 0.01% |
3,916,200
+3,183,404
| +434% | +$12.1M |
|
1138
The RealReal
REAL
$1.37B
| $24M | 0.01% |
1,822,217
+406,798
| +29% | +$6.03M |
|
1139
PUT
Canadian Imperial Bank of Commerce
CM
$107B
| $24M | 0.01% |
+340,000
| New | +$19.6M |
|
1140
CALL
United States Oil Fund
USO
$2B
| $23.9M | 0.01% |
455,200
| – | – |
|
1141
Smith & Nephew
SNN
$12.2B
| $23.9M | 0.01% |
696,613
-147,846
| -18% | -$5.82M |
|
|
UNVR
1142
DELISTED
Univar Solutions Inc.
UNVR
| $23.7M | 0.01% |
996,938
-18,601
| -2% | -$440K |
|
1143
Vanguard Extended Market ETF
VXF
$31.4B
| $23.7M | 0.01% |
130,157
+21,812
| +20% | +$4.07M |
|
1144
SSR Mining
SSRM
$7.74B
| $23.7M | 0.01% |
1,631,079
+456,725
| +39% | +$7.24M |
|
|
PARA
1145
PUT
DELISTED
Paramount Global Class B
PARA
| $23.7M | 0.01% |
600,500
+265,000
| +79% | +$10.8M |
|
1146
CALL
Regeneron Pharmaceuticals
REGN
$85.5B
| $23.7M | 0.01% |
39,200
-28,800
| -42% | -$17.9M |
|
1147
Emcor
EME
$33.5B
| $23.7M | 0.01% |
205,296
+46,684
| +29% | +$5.59M |
|
1148
Stanley Black & Decker
SWK
$14.8B
| $23.7M | 0.01% |
135,099
+20,021
| +17% | +$3.9M |
|
1149
Service Corp International
SCI
$11.4B
| $23.7M | 0.01% |
392,571
+224,228
| +133% | +$13.6M |
|
1150
CALL
US Global Jets ETF
JETS
$803M
| $23.6M | 0.01% |
1,000,000
+800,000
| +400% | +$18.5M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.